144 related articles for article (PubMed ID: 32053002)
1. Utility of T2 mapping in the staging of thyroid-associated ophthalmopathy: efficiency of region of interest selection methods.
Chen W; Hu H; Chen HH; Su GY; Yang T; Xu XQ; Wu FY
Acta Radiol; 2020 Nov; 61(11):1512-1519. PubMed ID: 32053002
[TBL] [Abstract][Full Text] [Related]
2. Thyroid-Associated Ophthalmopathy: Preliminary Study Using T2 Mapping to Characterize Intraorbital Optic Nerve Changes Before Dysthyroid Optic Neuropathy.
Hu H; Chen HH; Chen W; Wu Q; Chen L; Zhu H; Shi HB; Xu XQ; Wu FY
Endocr Pract; 2021 Mar; 27(3):191-197. PubMed ID: 33630733
[TBL] [Abstract][Full Text] [Related]
3. Three dimensional orbital magnetic resonance T2-mapping in the evaluation of patients with Graves' ophthalmopathy.
Hou K; Ai T; Hu WK; Luo B; Wu YP; Liu R
J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):938-942. PubMed ID: 29270757
[TBL] [Abstract][Full Text] [Related]
4. T2 mapping histogram at extraocular muscles for predicting the response to glucocorticoid therapy in patients with thyroid-associated ophthalmopathy.
Hu H; Chen HH; Chen W; Wu Q; Chen L; Zhu H; Xu XQ; Shi HB; Wu FY
Clin Radiol; 2021 Feb; 76(2):159.e1-159.e8. PubMed ID: 33010933
[TBL] [Abstract][Full Text] [Related]
5. Dynamic contrast-enhanced MRI in orbital lymphoproliferative disorders: Effects of region of interest selection methods on time efficiency, measurement reproducibility, and diagnostic ability.
Qian W; Xu XQ; Hu H; Su GY; Wu JF; Shi HB; Wu FY
J Magn Reson Imaging; 2018 May; 47(5):1298-1305. PubMed ID: 28922524
[TBL] [Abstract][Full Text] [Related]
6. Performance of T2 mapping in the staging of Graves' ophthalmopathy based on different region of interest selection methods.
Yang L; Dai X; Su J; Yang S; Zheng Y; Ma M; Yu S
Acta Radiol; 2024 May; ():2841851241248640. PubMed ID: 38767046
[TBL] [Abstract][Full Text] [Related]
7. Application of Multiparameter Quantitative Magnetic Resonance Imaging in the Evaluation of Graves' Ophthalmopathy.
Li Z; Luo Y; Feng X; Zhang Q; Zhong Q; Weng C; Chen Z; Shen J
J Magn Reson Imaging; 2023 Oct; 58(4):1279-1289. PubMed ID: 36780178
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of two-point Dixon T2-weighted imaging in thyroid-associated ophthalmopathy: comparison with conventional fat saturation imaging in fat suppression quality and staging performance.
Chen L; Hu H; Chen HH; Chen W; Wu Q; Wu FY; Xu XQ
Br J Radiol; 2021 Feb; 94(1118):20200884. PubMed ID: 33353397
[TBL] [Abstract][Full Text] [Related]
9. Prediction of treatment response to intravenous glucocorticoid in patients with thyroid-associated ophthalmopathy using T2 mapping and T2 IDEAL.
Zhai L; Luo B; Wu H; Wang Q; Yuan G; Liu P; Ma Y; Zhao Y; Zhang J
Eur J Radiol; 2021 Sep; 142():109839. PubMed ID: 34252869
[TBL] [Abstract][Full Text] [Related]
10. Baseline Volumetric T2 Relaxation Time Histogram Analysis: Can It Be Used to Predict the Response to Intravenous Methylprednisolone Therapy in Patients With Thyroid-Associated Ophthalmopathy?
Liu P; Luo B; Chen L; Wang QX; Yuan G; Jiang GH; Zhang J
Front Endocrinol (Lausanne); 2021; 12():614536. PubMed ID: 33716970
[TBL] [Abstract][Full Text] [Related]
11. [The value of DCE-MRI in assessing the course of thyroid associated ophthalmopathy].
Wu T; Tang DR; Wang F; Xia S; Sun FY
Zhonghua Yan Ke Za Zhi; 2017 Jun; 53(6):430-435. PubMed ID: 28606264
[No Abstract] [Full Text] [Related]
12. Multiparametric magnetic resonance imaging for differentiating active from inactive thyroid-associated ophthalmopathy: Added value from magnetization transfer imaging.
Hu H; Chen L; Zhou J; Chen W; Chen HH; Zhang JL; Hsu YC; Xu XQ; Wu FY
Eur J Radiol; 2022 Jun; 151():110295. PubMed ID: 35405579
[TBL] [Abstract][Full Text] [Related]
13. T2 Mapping with and without Fat-Suppression to Predict Treatment Response to Intravenous Glucocorticoid Therapy for Thyroid-Associated Ophthalmopathy.
Zhai L; Wang Q; Liu P; Luo B; Yuan G; Zhang J
Korean J Radiol; 2022 Jun; 23(6):664-673. PubMed ID: 35555881
[TBL] [Abstract][Full Text] [Related]
14. [The application of
Tang MT; Zeng XY; Li Y; Sun HT; Liu SY; Yuan X; Lu W
Zhonghua Yan Ke Za Zhi; 2021 Nov; 57(11):830-836. PubMed ID: 34743468
[No Abstract] [Full Text] [Related]
15. Quantitative evaluation of activity of thyroid-associated Ophthalmopathy using short-tau inversion recovery (STIR) sequence.
Ge Q; Zhang X; Wang L; Fan Y; Huang Q; Yao N; Long J; Liu C
BMC Endocr Disord; 2021 Nov; 21(1):226. PubMed ID: 34774035
[TBL] [Abstract][Full Text] [Related]
16. Correlation between extent of lacrimal gland prolapse and clinical features of thyroid-associated ophthalmopathy: a retrospective observational study.
Gao Y; Chang Q; Li Y; Zhang H; Hou Z; Zhang Z; Li Z; Li D
BMC Ophthalmol; 2022 Feb; 22(1):66. PubMed ID: 35144579
[TBL] [Abstract][Full Text] [Related]
17. Radiological Staging of Thyroid-Associated Ophthalmopathy: Comparison of T1 Mapping with Conventional MRI.
Chen L; Chen W; Chen HH; Wu Q; Xu XQ; Hu H; Wu FY
Int J Endocrinol; 2020; 2020():2575710. PubMed ID: 33144856
[TBL] [Abstract][Full Text] [Related]
18. T2 Relaxation Time in Extraocular Muscles of Patients with Mild Thyroid- Associated Ophthalmopathy: Comparing T2 Mapping With and Without Fat Suppression Using Different Measurement Methods.
Li D; Guo X; Zeng J; Feng H; Zhu T; Li H
Curr Med Imaging; 2024 Apr; ():. PubMed ID: 38639286
[TBL] [Abstract][Full Text] [Related]
19. Correlation Analysis between Intraocular Pressure and Extraocular Muscles Based on Orbital Magnetic Resonance T2 Mapping in Thyroid-Associated Ophthalmopathy Patients.
Luo B; Wang W; Li X; Zhang H; Zhang Y; Hu W
J Clin Med; 2022 Jul; 11(14):. PubMed ID: 35887744
[TBL] [Abstract][Full Text] [Related]
20. Dixon MRI-based quantitative parameters of extraocular muscles, intraorbital fat, and lacrimal glands for staging thyroid-associated ophthalmopathy.
Pu XY; Chen L; Hu H; Wu Q; Jiang WH; Lu JL; Chen HH; Xu XQ; Wu FY
Insights Imaging; 2024 Jun; 15(1):136. PubMed ID: 38853188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
